SAFETY OF USING METHOTREXATE SOLUTION FOR SUBCUTANEOUS INJECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS

Objective: to evaluate the safety of treatment with methotrexate (MT) solution for subcutaneous injections in patients with rheumatoid arthritis (RA).Subjects and methods. 237 RA patients enrolled in the study within the REMARCA protocol were given MT solution for subcutaneous injections (Metoject)...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Yu. V. Muravyev, G. I. Gridneva, D. E. Karateev, E. L. Luchichina
Aineistotyyppi: Artigo
Kieli:Russo
Julkaistu: IMA-PRESS LLC 2015-09-01
Sarja:Научно-практическая ревматология
Aiheet:
rheumatoid arthritis
safety
methotrexate solution for subcutaneous injections
adverse events
Linkit:https://rsp.mediar-press.net/rsp/article/view/2106
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia